Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/1995
04/06/1995WO1995009006A1 Monoglyceride/lactate ester permeation enhancer
04/06/1995WO1995009005A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m
04/06/1995WO1995008993A1 Oral formulations of an antifungal
04/06/1995WO1995008991A1 Parenteral busulfan for treatment of malignant disease
04/06/1995WO1995008984A1 Aerosol composition for forming a preferably hydrated membrane, preferably hydrated membrane so obtained, and applications thereofparticularly as a dressing
04/06/1995WO1995008981A1 Contraceptive compositions
04/06/1995WO1995003830A3 Prodrugs of farnesyl transferase inhibitors for adept or vdept
04/06/1995CA2173101A1 Contraceptive compositions
04/06/1995CA2172987A1 Pyrrolidone-group-containing polyesters and polyamides
04/06/1995CA2172808A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m
04/06/1995CA2167526A1 Monoglyceride/lactate ester permeation enhancer
04/06/1995CA2165802A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin
04/06/1995CA2133614A1 Retinol containing anhydrous and stable cosmetic or pharmaceutical composition for skin and use thereof for the treatment of skin diseases
04/06/1995CA2133002A1 Method of regulating blood amino acid levels
04/05/1995EP0646379A1 Insulin formulation
04/05/1995EP0646375A1 Method of regulating blood amino acid levels
04/05/1995EP0646371A1 Anhydrous cosmetic or pharmaceutical composition containing retinol
04/05/1995EP0646368A1 A gel-resembling composition containing organopolysiloxane, without a gelling agent used in cosmetic and dermatology
04/05/1995EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host
04/05/1995EP0646019A1 Pretargeting methods and compounds
04/05/1995EP0646018A1 Arabinogalactan derivatives and uses thereof
04/05/1995EP0646003A1 Preparation and use of novel cyclodextrin-based dispersible colloidal systems in the form of nanospheres.
04/05/1995EP0646002A1 Preparation and use of novel cyclodextrin-based dispersible nanovesicular colloidal systems in the form of nanocapsules.
04/05/1995EP0646000A1 Compositions using microencapsulated neutralizing antibodies
04/05/1995EP0645997A1 Cosmetic containing phospholipids and fluorocarbon compounds.
04/05/1995EP0469082B1 Liposomal targeting of ischemic tissue
04/05/1995EP0464163B1 Use of supercritical fluids to obtain porous sponges of biodegradable polymers
04/05/1995CA2133513A1 Gel like organopolysiloxane composition without gelling agent, useful in cosmetic and dermatological applications
04/04/1995US5403928 Fluorescent marker components and fluorescent probes
04/04/1995US5403893 Interpenetrating-polymer network phase-transition gels
04/04/1995US5403858 Perfusion solution ethanol free; antitumor agents
04/04/1995US5403841 Administrable as drops that gel upon installation in the eye
04/04/1995US5403840 Inclusion complexes of N-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing the same
04/04/1995US5403828 Removing uncomplexed componenet from complex by solvent extraction
04/04/1995US5403727 Allowing galactosidase to act on solution of lactoneotrehalose
04/04/1995US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label
04/04/1995US5403575 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
04/04/1995US5403574 Evaluation and treatment of the multidrug resistance phenotype
04/04/1995CA2046910C Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents
04/04/1995CA1335076C Pharmaceutical composition and method for intranasal administration
03/1995
03/31/1995CA2133180A1 Rapamycin formulation for iv injection
03/31/1995CA2133179A1 Rapamycin formulation for iv injection
03/31/1995CA2133174A1 Rapamycin formulations for oral administration
03/30/1995WO1995008349A1 COMPOSITION CONTAINING OMEGA 3 AND/OR OMEGA 6 POLYUNSATURATED ACIDS HAVING FROM 12 to 22 CARBON ATOMS
03/30/1995WO1995008348A1 Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
03/30/1995WO1995008323A1 Budesonide pellets with a controlled release pattern and process for producing them
03/29/1995EP0645145A2 Stabilized pharmaceutical composition and stabilizing solvent
03/29/1995EP0645140A1 Compositions for rectal administration containing benzimidazoles and fatty acid salts
03/29/1995EP0645048A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications
03/29/1995EP0644777A1 Microparticles, method of producing them and their use for diagnostic purposes
03/29/1995EP0644776A1 Use of microcapsules as contrasting agents in colour doppler sonography
03/29/1995EP0644771A1 Erythropoietin drug delivery system
03/29/1995EP0644770A1 Stabilized somatotropin for parenteral administration
03/29/1995EP0644746A1 The use of glycerin in moderating transdermal drug delivery
03/29/1995EP0436005B1 Labeled polypeptide derivatives
03/29/1995CN1100638A Ear drops specially for otitis media
03/29/1995CA2117394A1 Biodegradable implant precursor
03/28/1995US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment
03/28/1995US5401742 Polymeric conjugate of methotrexate compound and pyran copolymer and method for the preparation thereof
03/28/1995US5401723 Antisticking agents
03/28/1995US5401721 Antiulcer agents and antisecretory agents
03/28/1995US5401516 Encapsulation of biologically active materials, drug delivery, reaction with benzenesulfonyl chloride or benzoyl chloride
03/28/1995US5401512 Antiulcer agents with 5-aminosalicylic acid with topical steroids
03/28/1995US5401511 Phosphatidylethanolamine, hyaluronic acid, drug delivery
03/28/1995US5401489 Biomodulators as universal imaging agents
03/28/1995CA2029046C Sustained release compositions for treating periodontal disease
03/28/1995CA1334935C Dithranol compositions
03/28/1995CA1334934C Antibacterial composition for oral administration
03/28/1995CA1334933C Pharmaceutical composition and process for its preparation
03/23/1995WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995WO1995007936A1 Dextrane esters, process for producing them and their use for encasing and encapsulating medicaments
03/23/1995WO1995007923A1 Multi-unit ribozyme inhibition of oncogene expression
03/23/1995WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy
03/23/1995WO1995007707A1 Alteration of immune response using pan dr-binding peptides
03/23/1995WO1995007699A1 Novel method of progesterone delivery and affect thereof
03/23/1995WO1995007691A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
03/23/1995WO1995007683A1 Composition containing phosphate derivatives
03/23/1995WO1994029469A3 Plasmids suitable for gene therapy
03/23/1995CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995CA2170489A1 Composition containing phosphate derivatives
03/23/1995CA2132608A1 Pro-prodrugs, their production and use
03/23/1995CA2132511A1 Use of partly methylated .beta.-cyclodextrines as absorption promoters for the preparation of pharmaceutical compositions to be used for transcutaneous dispensing of activeingredients
03/22/1995EP0644156A1 Calcium hydrogen phosphate, a method for preparing it, and an excipient utilizing it
03/22/1995EP0643968A1 Molded pharmaceutical form for oral delivery of acetylsalicyclic acid or its salts and method to prepare it
03/22/1995EP0643962A1 New galenic dosage form for phloroglucinol
03/22/1995EP0643737A1 Conversion of powdered polymers
03/22/1995EP0643706A1 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
03/22/1995EP0643584A1 Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material
03/22/1995EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
03/22/1995EP0643578A1 A new composition containing selegiline
03/22/1995EP0585355B1 Multi-layered controlled release formulation
03/22/1995CN1100426A Lysosomal enzyme-cleavable antitumor drug conjugates
03/22/1995CN1100316A Medicinal composite for medical health cap
03/21/1995US5399700 Method for preparing enteric-coated oral drugs containing acid-unstable compounds
03/21/1995US5399672 Coupling hapten to protein or polypeptide in solvent
03/21/1995US5399671 Specifically crosslinked hemoglobin with free functionality
03/21/1995US5399665 Biodegradable polymers for cell transplantation
03/21/1995US5399554 Viricides
03/21/1995US5399551 Enhancer for the antianemia effect of erythropoietin and method of augmenting the antianemia effect of erythropoietin
03/21/1995US5399363 IV administration for insoluble medicaments
1 ... 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 ... 1712